May

Do healthcare business owners risk the financial health of their companies by acting as “lone wolves” on big decisions? This new study says “yes” -- but has a solution.

Former U.S. Senator Tom Daschle gives his viewpoint on healthcare reform legislation and the obstacles ahead. Read more to learn about the legal, administrative and regulatory challenges ahead as a result of this major legislation.

A treatment for tinnitus is the goal of two Ohio University colleagues who were frustrated by the lack of options for those suffering from this hearing disorder. Read more to find out how this medical device differs from its competitors.

Medical device startups need to know when it’s worthwhile to make use of the pre-IDE process. The FDA review team can provide valuable insight to the medical business, but there are drawbacks, too. Read more to find out the pros and cons of the pre-IDE process.

Health IT, innovation and business models are some of the topics addressed in this Q&A session with Richard Foster, a new partner at venture capital firm Lux Capital. Read more for his views on the future of health IT and his advice for new entrepreneurs.

A venture capital fund that has helped Ohio companies and created jobs has an unclear future. The Ohio Capital Fund is waiting on new legislation to help it continue. Read more to find out how this state-backed venture program works.

Healthcare investment in seed-stage companies is falling, and healthcare deals decreased as well. Read more to find out the details about how new healthcare businesses fared in a recent report.

Hospital navigation is easier on patients and visitors, thanks to a touch-screen kiosk with maps and instructions. In order to save staff time and improve patient satisfaction, some hospitals are using LogicJunction’s Wayfinder. Read more to learn about the market for this healthcare software.

A new biomedical endowment at Duke University will support a program that has already launched new healthcare businesses. Read more to find out about Duke’s successes in commercializing medical technology.

Proposed federal budget cuts could hurt healthcare innovation in America and be bad for patients. Read more to find out why giving Medicare the power to negotiate drug prices is a bad idea.